PURPOSE: We determined the degree of anxiety, embarrassment and discomfort anticipated by patients before undergoing videourodynamics and compared the results to the actual degrees experienced by patients. In addition, we compared these variables between men and women, and younger and older patients. MATERIALS AND METHODS: All patients undergoing urodynamics for the first time were given a 2 part questionnaire. Patients with neurological disease or those requiring an indwelling or intermittent catheter were excluded. Part 1 given immediately prior to the test contained 5 questions regarding expected anxiety, pain, embarrassment, apprehension regarding x-ray exposure and preparedness. Part 2 given immediately after testing contained 5 questions comparing anticipated to actual overall experience, pain and embarrassment, preparation and whether the patient would undergo testing again. Each question had a 5 point scale. RESULTS: A total of 78 men and 88 women respondents completed the questionnaires. Most (greater than 95% per question) expected no to moderate anxiety, pain, embarrassment and apprehension. This did not vary with age, although more women anticipated greater embarrassment and more men expected little or no embarrassment (p <0.001). After testing most respondents (greater than 90% per question) thought that the test was the same or better than expected and it was associated with an expected or less than expected level of pain and embarrassment. This did not vary between the sexes but more younger individuals found that the test experience was worse than expected, while more older individuals found that it was better than expected. Of the patients 95% would undergo urodynamic testing again if medically indicated. CONCLUSIONS: Videourodynamics is well tolerated and is associated with only minimal to moderate degrees of anxiety, discomfort and embarrassment. A suspected lack of tolerance should not be a barrier to performing medically indicated urodynamic testing.
PURPOSE: We determined the degree of anxiety, embarrassment and discomfort anticipated by patients before undergoing videourodynamics and compared the results to the actual degrees experienced by patients. In addition, we compared these variables between men and women, and younger and older patients. MATERIALS AND METHODS: All patients undergoing urodynamics for the first time were given a 2 part questionnaire. Patients with neurological disease or those requiring an indwelling or intermittent catheter were excluded. Part 1 given immediately prior to the test contained 5 questions regarding expected anxiety, pain, embarrassment, apprehension regarding x-ray exposure and preparedness. Part 2 given immediately after testing contained 5 questions comparing anticipated to actual overall experience, pain and embarrassment, preparation and whether the patient would undergo testing again. Each question had a 5 point scale. RESULTS: A total of 78 men and 88 women respondents completed the questionnaires. Most (greater than 95% per question) expected no to moderate anxiety, pain, embarrassment and apprehension. This did not vary with age, although more women anticipated greater embarrassment and more men expected little or no embarrassment (p <0.001). After testing most respondents (greater than 90% per question) thought that the test was the same or better than expected and it was associated with an expected or less than expected level of pain and embarrassment. This did not vary between the sexes but more younger individuals found that the test experience was worse than expected, while more older individuals found that it was better than expected. Of the patients 95% would undergo urodynamic testing again if medically indicated. CONCLUSIONS: Videourodynamics is well tolerated and is associated with only minimal to moderate degrees of anxiety, discomfort and embarrassment. A suspected lack of tolerance should not be a barrier to performing medically indicated urodynamic testing.
Authors: Benjamin Abelson; Steve Majerus; Daniel Sun; Bradley C Gill; Eboo Versi; Margot S Damaser Journal: Nat Rev Urol Date: 2019-05 Impact factor: 14.432
Authors: Amanda L Lewis; Grace J Young; Lucy E Selman; Caoimhe Rice; Clare Clement; Cynthia A Ochieng; Paul Abrams; Peter S Blair; Christopher Chapple; Cathryn Ma Glazener; Jeremy Horwood; John S McGrath; Sian Noble; Gordon T Taylor; J Athene Lane; Marcus J Drake Journal: Health Technol Assess Date: 2020-09 Impact factor: 4.014
Authors: Anne M Suskind; J Quentin Clemens; Samuel R Kaufman; John T Stoffel; Ann Oldendorf; Bahaa S Malaeb; Teresa Jandron; Anne P Cameron Journal: Urology Date: 2015-03 Impact factor: 2.649
Authors: Sarah Milosevic; Natalie Joseph-Williams; Bethan Pell; Elizabeth Cain; Robyn Hackett; Ffion Murdoch; Haroon Ahmed; A Joy Allen; Alison Bray; Samantha Clarke; Marcus J Drake; Michael Drinnan; Kerenza Hood; Tom Schatzberger; Yemisi Takwoingi; Emma Thomas-Jones; Raymond White; Adrian Edwards; Chris Harding Journal: Diagn Progn Res Date: 2021-05-18
Authors: Lucy E Selman; Cynthia A Ochieng; Amanda L Lewis; Marcus J Drake; Jeremy Horwood Journal: Neurourol Urodyn Date: 2018-10-12 Impact factor: 2.696
Authors: Ivan Nenadic; Lance Mynderse; Douglas Husmann; Mohammad Mehrmohammadi; Mahdi Bayat; Aparna Singh; Max Denis; Matthew Urban; Azra Alizad; Mostafa Fatemi Journal: PLoS One Date: 2016-06-24 Impact factor: 3.240